This gene-editing therapy could cure sickle cell disease, and it’s close to FDA approval
A breakthrough treatment for sickle cell patients could soon become the first gene-editing treatment to be approved by the Food and Drug Administration (FDA).
Sickle cell disease (SCD) is an inherited blood disorder that affects…